Where to Buy NAD+: Priced per 100 mg, Channel by Channel

Read the last column first. It is the one that decides whether you can do arithmetic at all, and four of the five channels fail it.

The pattern is worth naming. The cheapest channel by published unit price is the one with the least oversight, and the most supervised channel is the one that will not quote you a unit price. Nothing in this article resolves that tension. It is the shape of the market.

This channel sells lyophilised NAD+ by the gram, labelled for laboratory use and not for human consumption, with no prescriber involved. Ascension Peptides lists one NAD+ product, 1,000 mg, at $104.00, halving to $52.00 with the code PEPTIDEDECK. That is $5.20 per 100 mg, and $10.40 per 100 mg without the code.

The reason this channel can publish a unit price is that it sells a defined quantity of a defined substance and nothing else. There is no administration, no facility, no clinician time folded into the figure. That transparency is genuinely the channel's strength and it is also exactly why the transparency stops where it does: nobody in the chain is accountable for what happens after the box arrives, so the specification stops at identity and purity.

The published certificates make the boundary visible. MZ Biolabs reports lot 25-01260229, analysed 26 January 2026 by HPLC-UV-MS, purity 99.66%, identity confirmed by mass spectrometry, measured quantity 784.32 mg per vial. Kovera Labs covers batch 25-05260628, dated 14 June 2026. Two independent laboratories per batch is more than most of this channel publishes. Neither certificate we could open reports a bacterial endotoxins result, which is the one line that would speak to the risk FDA has actually documented for this compound.

Price it on both bases while you are here. $52.00 over the labelled 1,000 mg is $5.20 per 100 mg. $52.00 over the assayed 784.32 mg is $6.63 per 100 mg, and our NAD+ where to buy page explains why the two figures differ and why the difference is not a short fill.

This is the channel peptides do not have. Wellness clinics, med spas and mobile IV services sell NAD+ infusions openly and advertise them for fatigue, focus, recovery and ageing. Those are marketing claims, they are not approved indications, and this page reports that they are made without adopting them.

The commercial structure is consistent even though the numbers are not. Clinics price a session or a course rather than a quantity: an infusion slot, sometimes a membership, frequently a package of several sessions sold at a discount to the single-session rate. Some list the milligram content of the bag and some do not. Chair time is part of what you are paying for, because a gram-scale infusion is not a five minute appointment.

We are not going to invent a dollar range for that, because clinic pricing varies by city, by service and by whether a nurse travels to you, and a made-up range is worse than none. What we can say is structural: when a channel prices a session and a competing channel prices a gram, the two are not directly comparable until the clinic tells you the milligrams in the bag. Ask. If a clinic will not state the quantity, the price it quoted you cannot be converted into anything.

The second question matters more. Ask where the preparation was compounded, whether the bulk substance was pharmaceutical grade, and whether the compounder holds an endotoxin result for the lot. That is not an aggressive question. It is the question FDA's own notice implies, and a clinic with a good supply chain will have an answer ready. Our NAD+ near me page covers the local search in more detail.

A compounding pharmacy prepares a patient-specific preparation against a prescription. That makes it the most supervised channel on the list, and it is also the channel FDA wrote a notice about.

In a compounding notice whose content is current as of 30 October 2024, the agency said it was aware of compounders using food-grade nicotinamide adenine dinucleotide sold by repackagers to make intravenous products. Ingredients identified as food grade, it said, are not suitable for compounding sterile drugs without appropriate processing, because of the high risk of contamination with microbes and endotoxins. It went on to report adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, some requiring medical treatment, consistent with excessive levels of endotoxins.

Read what that implies about the whole market. The supervised channel was buying from repackagers, and the failure was not identity or potency but grade. A prescription does not test the powder. It authorises a preparation from powder somebody else sourced.

On the regulatory side, Nicotinamide Adenine Dinucleotide (NAD) appears in Category 1 of FDA's list of bulk drug substances nominated for use in compounding under section 503A, updated 14 May 2026, together with the reduced disodium form. Category 1 means FDA does not intend to take action against a compounder using the substance provided the conditions in its guidance are met, while it continues to evaluate. That is non-enforcement pending evaluation rather than approval, and the list is explicitly provisional. A separate Beta-NAD entry sits in Category 3, which is a different position under a name that looks like the same substance. Our NAD+ without prescription page sets the categories out in full.

Overseas marketplaces. Bulk listings on international trade platforms quote low kilogram prices and almost never publish a batch certificate you can match to what arrives. The failure modes stack: no lot traceability, a parcel crossing a border with no return path, and a seller you cannot reach if the material is wrong. A per 100 mg figure calculated from such a listing is arithmetic performed on a number nobody stands behind.

The supplement aisle. Shelves are full of NMN and NR, which are NAD+ precursors rather than NAD+, taken orally rather than prepared as a solution. They are a genuinely different purchase with their own separate history, and this site does not assert their regulatory status because we have not verified it. What is safe to say is narrower and more useful: a capsule of a precursor is not the compound priced at $5.20 per 100 mg on this page, and the two cannot be put in the same table.

Both of these channels exist mainly because the first three are awkward, and neither improves on them.

Once you have milligrams, the arithmetic is short. This is laboratory handling maths, not a protocol, and dosing questions belong on the NAD+ dosage page rather than here.

Check the vial's physical capacity before assuming 10 mL of diluent fits, because headspace is a real constraint at gram scale. The NAD+ calculator will run any volume you enter and our reconstitution guide covers the method generally.

To convert a clinic quote, divide the session price by the milligrams in the bag and multiply by 100. If you cannot get the milligrams, you have not been given a comparable number and no amount of arithmetic will produce one.